Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Bidlingmaier

Showing results (21-30 of 27) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 27 results.
Der Nervenarzt|January 24, 2022
[Stroke alarm-Arterial ischemic stroke as one of the most time-critical emergencies in children and adolescents]Lucia Gerstl, M Olivieri, F Heinen, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|February 18, 2015
Presentation and management of acute coronary syndromes among adult persons with haemophilia: results of an international, retrospective, 10-year surveyP F Fogarty, M E Mancuso, R Kasthuri, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|November 22, 2016
Evaluation of the utility of the ISTH-BAT in haemophilia carriers: a multinational studyP D James, J Mahlangu, C Bidlingmaier, et al.
Hamostaseologie|November 8, 2011
Inhibitor-immunology-study. Evaluation of inhibitor development in haemophilia BI Wieland, C Wermes, B Eifrig, et al.
Hamostaseologie|November 5, 2008
Inhibitor-Immunology-Study. Different HLA-types seem to be involved in the inhibitor development in haemophilia AI Wieland, C Wermes, B Eifrig, et al.
Journal of Thrombosis and Haemostasis : JTH|March 30, 2010
Rate of inhibitor development in previously untreated hemophilia A patients treated with plasma-derived or recombinant factor VIII concentrates: a systematic reviewA Iorio, S Halimeh, S Holzhauer, et al.
Journal of Thrombosis and Haemostasis : JTH|February 11, 2012
Coagulation factor activity and clinical bleeding severity in rare bleeding disorders: results from the European Network of Rare Bleeding DisordersF Peyvandi, R Palla, M Menegatti, et al.
Pageof 3

Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
Der Nervenarzt|January 24, 2022
[Stroke alarm-Arterial ischemic stroke as one of the most time-critical emergencies in children and adolescents]Lucia Gerstl, M Olivieri, F Heinen, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|February 18, 2015
Presentation and management of acute coronary syndromes among adult persons with haemophilia: results of an international, retrospective, 10-year surveyP F Fogarty, M E Mancuso, R Kasthuri, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|November 22, 2016
Evaluation of the utility of the ISTH-BAT in haemophilia carriers: a multinational studyP D James, J Mahlangu, C Bidlingmaier, et al.
Hamostaseologie|November 8, 2011
Inhibitor-immunology-study. Evaluation of inhibitor development in haemophilia BI Wieland, C Wermes, B Eifrig, et al.
Hamostaseologie|November 5, 2008
Inhibitor-Immunology-Study. Different HLA-types seem to be involved in the inhibitor development in haemophilia AI Wieland, C Wermes, B Eifrig, et al.
Journal of Thrombosis and Haemostasis : JTH|March 30, 2010
Rate of inhibitor development in previously untreated hemophilia A patients treated with plasma-derived or recombinant factor VIII concentrates: a systematic reviewA Iorio, S Halimeh, S Holzhauer, et al.
Journal of Thrombosis and Haemostasis : JTH|February 11, 2012
Coagulation factor activity and clinical bleeding severity in rare bleeding disorders: results from the European Network of Rare Bleeding DisordersF Peyvandi, R Palla, M Menegatti, et al.
Pageof 3